Volume 53, Issue 5, Pages (May 1998)

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

Volume 64, Issue 1, Pages (July 2003)
Volume 77, Issue 9, Pages (May 2010)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 62, Issue 1, Pages (July 2002)
Volume 64, Issue 6, Pages (December 2003)
Volume 65, Issue 4, Pages (April 2004)
Cell Physiol Biochem 2016;40: DOI: /
Osteopontin expression in acute renal allograft rejection
Volume 81, Issue 11, Pages (June 2012)
Osteopontin expression in human crescentic glomerulonephritis
Podocyte involvement in human immune crescentic glomerulonephritis
Volume 66, Issue 1, Pages (July 2004)
Volume 63, Issue 6, Pages (June 2003)
Volume 54, Issue 1, Pages (July 1998)
Volume 58, Issue 4, Pages (October 2000)
Volume 61, Issue 2, Pages (February 2002)
Volume 74, Issue 10, Pages (November 2008)
Expression of the C-C chemokine receptor 5 in human kidney diseases1
Volume 62, Issue 1, Pages (July 2002)
Volume 57, Issue 4, Pages (April 2000)
Volume 74, Issue 1, Pages (July 2008)
Volume 83, Issue 1, Pages (January 2013)
Volume 60, Issue 2, Pages (August 2001)
Volume 70, Issue 7, Pages (October 2006)
Volume 66, Issue 6, Pages (December 2004)
Volume 81, Issue 3, Pages (February 2012)
Volume 53, Issue 4, Pages (April 1998)
Mechanisms of the proteinuria induced by Rho GTPases
Volume 63, Issue 6, Pages (June 2003)
Volume 83, Issue 6, Pages (June 2013)
Volume 63, Issue 4, Pages (April 2003)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
αvβ6 integrin expression in diseased and transplanted kidneys
Volume 55, Issue 4, Pages (April 1999)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Volume 73, Issue 12, Pages (June 2008)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 57, Issue 2, Pages (October 2000)
Volume 70, Issue 8, Pages (October 2006)
Oliver Vonend, Clare M. Turner  Kidney International 
Volume 60, Issue 6, Pages (December 2001)
Volume 81, Issue 3, Pages (February 2012)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 59, Issue 4, Pages (April 2001)
Volume 55, Issue 2, Pages (February 1999)
Volume 73, Issue 1, Pages (January 2008)
Volume 79, Issue 6, Pages (March 2011)
Volume 70, Issue 11, Pages (December 2006)
Local macrophage proliferation in human glomerulonephritis
Volume 61, Issue 6, Pages (June 2002)
Volume 65, Issue 2, Pages (February 2004)
HIV-related nephropathy: A South African perspective
Expression of connective tissue growth factor in human renal fibrosis
Proteinuria and tubulointerstitial lesions in lupus nephritis
The Case | Idiopathic hypocomplementemic interstitial nephritis
Volume 62, Issue 2, Pages (August 2002)
Volume 56, Issue 5, Pages (November 1999)
Qiong Wu, Kiichiro Jinde, Masayuki Endoh, Hideto Sakai 
Nitric oxide, enhanced by macrophage-colony stimulating factor, mediates renal damage in reflux nephropathy  Udo Rolle, Hideki Shima, Prem Puri  Kidney.
Mechanisms of tubulointerstitial injury in IgA nephropathy
Volume 60, Issue 5, Pages (November 2001)
Volume 57, Issue 5, Pages (May 2000)
Volume 70, Issue 2, Pages (July 2006)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 69, Issue 10, Pages (May 2006)
Volume 73, Issue 5, Pages (March 2008)
Predictive value of urinary micro-cholesterol (mCHO) levels in patients with progressive glomerular disease  Osamu Hotta, Hisako Sugai, Hiroshi Kitamura,
Volume 56, Issue 3, Pages (September 1999)
Volume 55, Issue 5, Pages (May 1999)
Presentation transcript:

Volume 53, Issue 5, Pages 1190-1200 (May 1998) Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis  Takashi Oda, Osamu Hotta, Yoshio Taguma, Hiroshi Kitamura, Hisako Sugai, Shin Onodera, Ikuo Horigome, Kazuyuki Suzuki, Yoshiharu Shouji, Takashi Furuta, Shigemi Chiba, Nobuyuki Yoshizawa, Hiroshi Nagura  Kidney International  Volume 53, Issue 5, Pages 1190-1200 (May 1998) DOI: 10.1046/j.1523-1755.1998.00886.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Representative serial sections of PAS (A) and CD68 immunoperoxidase staining (B) in a case of IgA nephropathy (IgAN). Note prominent infiltration of enlarged cells in the tubules adjacent to the glomeruli which has small crescent (A). These cells are positive for macrophage marker CD68 (B) and were termed “giant macrophages” (G-Mφ). (C and D) Representative light microscopic view of PAS stained sections. Note the attachment of intratubular giant cells to tubular epithelial cells (arrows); such tubular epithelial cells often have cytoplasmic vacuoles (C) or hyaline droplet degenerative changes (D) (magnifications: A, B, ×630; C, ×1250; D, ×1900). Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Representative immunoperoxidase staining for CD68 with PAS counterstaining in tissues from rapidly progressive glomerulonephritis (RPGN) patients. Giant macrophages (G-Mφ) were usually found in the lumen of tubules, but occasionally in Bowmann's spaces (A, B), and rarely glomerular tufts (B, arrowheads) and flowing into tubular lumen (C; arrowheads). In most cases, glomerular intra-tuft CD68+ cells were small (A, arrows), but seemed to become quite large at the Bowmann's space level. In some patients, the giant cells were also found lining Bowman's capsules or lining tubular basement membrane (TBM) (D). Note the obvious difference in size between intratubular or intraglomerular G-Mφ and interstitial infiltrating Mφ. (E, F) Representative electron micrograph and oil red O staining of a biopsy tissue from a membranoproliferative glomerulonephritis (MPGN) patient with crescents. G-Mφ have vacuoles of various sizes (E), and contain a lot of lipid in the cytoplasm (F) (magnifications: A–C, ×810; D, ×1620; E, ×15000; F, ×2450). Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Representative immunoperoxidase staining for mature macrophage (Mφ) marker (25F9) (A), HLA-DR (B), and transferrin receptor (CD71) (C) in biopsy specimens from rapidly progressive glomerulonephritis (RPGN) patients. Note the strong cytoplasmic positivity of 25F9 and cell surface positivity of HLA-DR and CD71 on G-Mφ (magnifications: A, ×1250; B, ×940; C, ×1900). Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 A. Double staining for CD68 (immunoperoxidase-AEC: red) and cytokeratin (immuno-alkaline phosphatase: dark blue) in a biopsy specimen from a rapidly progressive glomerulonephritis (RPGN) patient. CD68 and cytokeratin are expressed on different cells, that is, cytokeratin is completely negative on G-Mφ. (B) Triple staining for CD68 (immunoperoxidase-DAB NiCl2: dark brown), ICAM-1 (immunoperoxidase-AEC: red) and chroloesterase (CHE: blue) in a biopsy specimen from a mesangioproliferative glomerulonephritis (MPGN) patient with crescents. Note the frequent touch of CD68-positive G-Mφ with ICAM-1-positive tubular epithelial cells (arrows). (C and D) Double staining for Ki-67 (immunoperoxidase-DAB NiCl2: dark brown), and CD68 (immunoperoxidase-AEC: red) in a biopsy specimen from an RPGN patient. Double positive cells were found (D is higher power view of the arrowed cell in C), but the labeling index of Ki-67 on CD68+ G-Mφ was very low (lower than 2.0%) (magnifications: A and B, ×1620; C, ×810; D, ×1620). Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 A. Intratubular giant macrophages (G-Mφ) in various primary glomerulonephritis (GN) and in tubulointerstitial nephritis (TIN). Few if any G-Mφ are found in TIN, minimal change nephrotic syndrome (MCNS) or in those with minor glomerular abnormalities (MGA). The G-Mφ number is significantly higher in focal segmental glomerulosclerosis (FGS), MPGN, and RPGN than in MGA. In membranous nephropathy (MN) and IgAN, the mean G-Mφ number appears higher than in MGA, but the difference is not statistically significant (*P < 0.05, **P < 0.01 vs. MGA). (B) GN patients were divided into two groups on the basis of the presence or absence of glomerular crescents (crescent+, 39 patients; crescent-, 57 patients). The G-Mφ number is significantly higher in the crescent+ group than in the crescent- group (6.3 ± 9.7 vs. 0.2 ± 0.5, P < 0.001). Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 A. Correlation between serum creatinine (SCr) levels and intratubular giant macrophages (G-Mφ) number in glomerulonephritis (GN) patients (r = 0.63, P < 0.001, N = 96). (B) G-Mφ numbers in each GN patient are plotted in relation to the urinary red blood cell (RBC) levels. The correlation is significant (ρ = 0.5, P < 0.001, N = 96, Spearman's rank correlation test). (C) Correlation between proteinuria levels and intratubular G-Mφ number in IgAN patients (r = 0.89, P < 0.001, N = 27). The correlation is not significant when all GN patients are included. Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 7 A. Double staining for CHE (neutrophil, blue) and nonspecific esterase (NSE: Mφ, red) in urinary sediments of an RPGN patient. Note the two types of NSE positive cells: one is smaller (arrowhead, ordinary monocyte/Mφ), and another is larger than neutrophils (arrow, probably the same as G-Mφ in renal tubules). (B) Triple staining for CD68 (immunoperoxidase-DAB: brown), cytokeratin (immunoperoxidase-AEC: red) and CHE (blue) in urinary sediments of an RPGN patient. Most cells are CD68-positive G-Mφ (arrowheads), and several epithelial cells and neutrophils are intermingled (magnifications: A, ×2450; B, ×1620). Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 8 Reverse transcription-polymerase chain reaction (RT-PCR) analysis for the detection of macrophage scavenger receptor (SR) types I and II and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. “M” represents the molecular size markers. (A.) RT-PCR products of total RNA isolated from urinary sediments of IgAN patients without crescents (lanes 1 to 3), with crescents (lanes 4 to 6) and RPGN patients (lanes 7 to 9). No bands or faint SR bands were observed in IgAN patients without crescents, while distinct bands were observed at the predicted size of both SR type I (451bp) and II (295bp) in IgAN patients with crescents and the RPGN patient. GAPDH bands (496bp) were essentially the same in the three groups. (B) RT-PCR products of total RNA isolated from renal biopsy tissues of IgAN patients without crescents (lanes 1 to 3), with crescents (lanes 4 to 6) and RPGN patients (lanes 7 to 9). Both SR type I and II bands were weak in intensity in IgAN patients without crescents, but were obviously strong in IgAN patients with crescents and RPGN patients. GAPDH bands were essentially the same. Kidney International 1998 53, 1190-1200DOI: (10.1046/j.1523-1755.1998.00886.x) Copyright © 1998 International Society of Nephrology Terms and Conditions